Frontier Capital Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-195,959
| Closed | -$14.7M | – | 278 |
|
|
2022
Q2 | $14.7M | Buy |
195,959
+80,062
| +69% | +$6.02M | 0.17% | 175 |
|
|
2022
Q1 | $3.11M | Sell |
115,897
-238,110
| -67% | -$6.39M | 0.03% | 256 |
|
|
2021
Q4 | $16.9M | Buy |
354,007
+139,249
| +65% | +$6.64M | 0.13% | 189 |
|
|
2021
Q3 | $14.3M | Sell |
214,758
-57,076
| -21% | -$3.79M | 0.11% | 197 |
|
|
2021
Q2 | $21.2M | Buy |
271,834
+268,135
| +7,249% | +$20.9M | 0.16% | 180 |
|
|
2021
Q1 | $350K | Sell |
3,699
-128,733
| -97% | -$12.2M | ﹤0.01% | 275 |
|
|
2020
Q4 | $16.1M | Buy |
132,432
+2,964
| +2% | +$361K | 0.12% | 202 |
|
|
2020
Q3 | $11.3M | Buy |
+129,468
| New | +$11.3M | 0.1% | 206 |
|